- Home
- PCYO vs SGMO Comparison
PCYO vs SGMO Comparison
Compare PCYO & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- SGMO
- Stock Information
- Founded
- PCYO 1976
- SGMO 1995
- Country
- PCYO United States
- SGMO United States
- Employees
- PCYO N/A
- SGMO N/A
- Industry
- PCYO Water Supply
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PCYO Utilities
- SGMO Health Care
- Exchange
- PCYO Nasdaq
- SGMO Nasdaq
- Market Cap
- PCYO 271.7M
- SGMO 242.0M
- IPO Year
- PCYO N/A
- SGMO 2000
- Fundamental
- Price
- PCYO $11.49
- SGMO $1.07
- Analyst Decision
- PCYO
- SGMO Buy
- Analyst Count
- PCYO 0
- SGMO 6
- Target Price
- PCYO N/A
- SGMO $5.17
- AVG Volume (30 Days)
- PCYO 35.5K
- SGMO 3.8M
- Earning Date
- PCYO 04-09-2025
- SGMO 03-12-2025
- Dividend Yield
- PCYO N/A
- SGMO N/A
- EPS Growth
- PCYO 103.72
- SGMO N/A
- EPS
- PCYO 0.55
- SGMO N/A
- Revenue
- PCYO $29,113,000.00
- SGMO $52,291,000.00
- Revenue This Year
- PCYO N/A
- SGMO N/A
- Revenue Next Year
- PCYO N/A
- SGMO N/A
- P/E Ratio
- PCYO $20.89
- SGMO N/A
- Revenue Growth
- PCYO 56.25
- SGMO N/A
- 52 Week Low
- PCYO $8.94
- SGMO $0.30
- 52 Week High
- PCYO $14.63
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- PCYO 43.48
- SGMO 37.60
- Support Level
- PCYO $11.23
- SGMO $1.07
- Resistance Level
- PCYO $12.25
- SGMO $1.24
- Average True Range (ATR)
- PCYO 0.28
- SGMO 0.09
- MACD
- PCYO 0.03
- SGMO 0.02
- Stochastic Oscillator
- PCYO 25.49
- SGMO 5.71
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.